 |
Surviving Cancer – now what?
Dr. Jennifer Jones has been researching prostate cancer survivorship since 1994. Read her story and watch her speak about her current research. Dr. Jennifer Jones discusses her recent research into prostate cancer survivorship.
|
 |
Study could help doctors decide which patients need treatment
A big challenge in prostate cancer is figuring out which men need treatment right away. Drs. Paul Boutros and Thomas Kislinger are close to identifying whether men have aggressive prostate cancer that needs immediate action. |
 |
Hidden clue in blood could help fight against aggressive prostate cancer
Dr. Hansen He is working to develop a blood test to distinguish slow-growing and aggressive prostate cancer. |
 |
Seeking answers to an aggressive form of advanced prostate cancer
Drs. Paul Boutros and Hansen He are looking for better treatments for a deadly type of prostate cancer – neuroendocrine prostate cancer. |
 |
Close to a breakthrough on an aggressive form of advanced prostate cancer
Dr. Amina Zoubeidi and her team are coming close to developing a drug to treat neuroendocrine prostate cancer – a deadly form of prostate cancer for which there is no effective treatment. |
 |
Reflecting on 25 years of impact
Dr. Laurence Klotz was part of the team that received Prostate Cancer Canada’s first research grant, which contributed to the development of active surveillance – an approach now used around the world. |
 |
Can you inherit prostate cancer?
Dr. Danny Verspirini and his team are studying the BRCA2 gene and its connection to prostate cancer. |
 |
Uncovering prostate cancer mysteries in unexpected places
Dr. Bapat Bharati and her team are looking at urine to see if there are markers in it for predict low-risk prostate cancer and cancer that is likely to spread. |
 |
Low oxygen in tumour cells leads to important discovery
Dr. Paul Boutros and his team have discovered markers in tumour cells with low oxygen that could predict cancer progression. |
 |
From idea to possibility: Moving research from the lab to patient care
Dr. Paul Rennie and his team are developing new ways to treat aggressive prostate cancer by targeting the cancer’s hormone receptors. |